[1]
|
Rubsam, A., Parikh, S. and Fort, P.E. (2018) Role of Inflammation in Diabetic Retinopathy. International Journal of Molecular Sciences, 19, 942. https://doi.org/10.3390/ijms19040942
|
[2]
|
Stefanini, F.R., Badaro, E., Falabella, P., et al. (2014) Anti-VEGF for the Management of Diabetic Macular Edema. Journal of Immunology Research, 2014, Article ID: 632307. https://doi.org/10.1155/2014/632307
|
[3]
|
Barber, A.J. (2003) A New View of Diabetic Ret-inopathy: A Neurodegenerative Disease of the Eye. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 27, 283-290. https://doi.org/10.1016/S0278-5846(03)00023-X
|
[4]
|
He, R.R. and Zhou, H.J. (2008) Progress in Research on the Anti-Tumor Effect of Artesunate. Chinese Journal of Integrative Medicine, 14, 312-316. https://doi.org/10.1007/s11655-008-0312-0
|
[5]
|
Chen, H.H. and Zhou, H.J. (2004) Inhibitory Effects of Ar-tesunate on Angiogenesis. Acta Pharmaceutica Sinica, 39, 29-33.
|
[6]
|
Zong, Y., Yuan, Y., Qian, X., et al. (2016) Small Molecular-Sized Artesunate Attenuates Ocular Neovascularization via VEGFR2, PKCalpha, and PDGFR Targets. Scientific Reports, 6, Article No. 30843. https://doi.org/10.1038/srep30843
|
[7]
|
Rocca, A., Tafuri, D., Paccone, M., et al. (2017) Cell Based Therapeutic Approach in Vascular Surgery: Application and Review. Open Medicine (Warsaw, Poland), 12, 308-322. https://doi.org/10.1515/med-2017-0045
|
[8]
|
Kowluru, R.A., Zhong, Q. and Santos, J.M. (2012) Matrix Metallo-proteinases in Diabetic Retinopathy: Potential Role of MMP-9. Expert Opinion on Investigational Drugs, 21, 797-805. https://doi.org/10.1517/13543784.2012.681043
|
[9]
|
Cronstein, B.N. and Weissmann, G. (1993) The Adhesion Molecules of Inflammation. Arthritis and Rheumatism, 36, 147-157. https://doi.org/10.1002/art.1780360204
|
[10]
|
Mackay, C.R. and Imhof, B.A. (1993) Cell Adhesion in the Immune System. Immunology Today, 14, 99-102. https://doi.org/10.1016/0167-5699(93)90205-Y
|
[11]
|
Schroder, S., Palinski, W. and Schmid-Schonbein, G.W. (1991) Activated Monocytes and Granulocytes, Capillary Nonperfusion, and Neovascularization in Diabetic Retinopathy. The American Journal of Pathology, 139, 81-100.
|
[12]
|
Joussen, A.M., Murata, T., Tsujikawa, A., et al. (2001) Leukocyte-Mediated Endothelial Cell Injury and Death in the Diabetic Retina. The American Journal of Pathology, 158, 147-152. https://doi.org/10.1016/S0002-9440(10)63952-1
|
[13]
|
Adamis, A.P., Shima, D.T., Tolentino, M.J., et al. (1996) Inhibition of Vascular Endothelial Growth Factor Prevents Retinal Ischemia-Associated Iris Neovascularization in a Nonhuman Primate. Archives of Ophthalmology, 114, 66-71. https://doi.org/10.1001/archopht.1996.01100130062010
|
[14]
|
Aiello, L.P., Pierce, E.A., Foley, E.D., et al. (1995) Suppression of Retinal Neovascularization in Vivo by Inhibition of Vascular Endothelial Growth Factor (VEGF) Using Soluble VEGF-Receptor Chimeric Proteins. Proceedings of the National Academy of Sciences of the United States of America, 92, 10457-10461. https://doi.org/10.1073/pnas.92.23.10457
|
[15]
|
Adamis, A.P. (2002) Is Diabetic Retinopathy an Inflammatory Disease? The British Journal of Ophthalmology, 86, 363-365. https://doi.org/10.1136/bjo.86.4.363
|
[16]
|
Joussen, A.M., Poulaki, V., Le, M.L., et al. (2004) A Central Role for Inflammation in the Pathogenesis of Diabetic Retinopathy. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 18, 1450-1452. https://doi.org/10.1096/fj.03-1476fje
|
[17]
|
El-Asrar, A.M. (2012) Role of Inflammation in the Pathogenesis of Diabetic Retinopathy. Middle East African Journal of Ophthalmology, 19, 70-74. https://doi.org/10.4103/0974-9233.92118
|
[18]
|
Steeber, D.A., Campbell, M.A., Basit, A., et al. (1998) Optimal Selectin-Mediated Rolling of Leukocytes during Inflammation in Vivo Requires Intercellular Adhesion Molecule-1 Expression. Proceedings of the National Academy of Sciences of the United States of America, 95, 7562-7567. https://doi.org/10.1073/pnas.95.13.7562
|
[19]
|
Williams, M.R. and Luscinskas, F.W. (2011) Leukocyte Rolling and Adhesion via ICAM-1 Signals to Endothelial Permeability. Focus on “Leukocyte Rolling and Adhesion both Contribute to Regulation of Microvascular Permeability to Albumin via Ligation of ICAM-1”. American Journal of Physiology. Cell Physiology, 301, C777-C779. https://doi.org/10.1152/ajpcell.00250.2011
|
[20]
|
Joussen, A.M., Poulaki, V., Mitsiades, N., et al. (2003) Suppres-sion of Fas-FasL-Induced Endothelial Cell Apoptosis Prevents Diabetic Blood-Retinal Barrier Breakdown in a Model of Streptozotocin-Induced Diabetes. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 17, 76-78. https://doi.org/10.1096/fj.02-0157fje
|
[21]
|
Rangasamy, S., McGuire, P.G. and Das, A. (2012) Diabetic Retinopathy and Inflammation: Novel Therapeutic Targets. Middle East African journal of ophthalmology, 19, 52-59. https://doi.org/10.4103/0974-9233.92116
|
[22]
|
Ram, M., Sherer, Y. and Shoenfeld, Y. (2006) Matrix Metallo-proteinase-9 and Autoimmune Diseases. Journal of Clinical Immunology, 26, 299-307. https://doi.org/10.1007/s10875-006-9022-6
|
[23]
|
Malemud, C.J. (2006) Matrix Metalloproteinases (MMPs) in Health and Disease: An Overview. Frontiers in Bioscience: A Journal and Virtual Library, 11, 1696-1701.
|
[24]
|
Giebel, S.J., Menicucci, G., McGuire, P.G., et al. (2005) Matrix Metalloproteinases in Early Diabetic Retinopathy and Their Role in Alteration of the Blood-Retinal Barrier. Laboratory Investigation: A Journal of Technical Methods and Pathology, 85, 597-607. https://doi.org/10.1038/labinvest.3700251
|
[25]
|
Matsumoto, K., Sera, Y., Ueki, Y., et al. (2002) Comparison of Serum Concentrations of Soluble Adhesion Molecules in Diabetic Microangiopathy and Macroangiopathy. Diabetic Medicine: A Journal of the British Diabetic Association, 19, 822-826. https://doi.org/10.1046/j.1464-5491.2002.00799.x
|
[26]
|
Limb, G.A., Hickman-Casey, J., Hollifield, R.D., et al. (1999) Vascular Adhesion Molecules in Vitreous from Eyes with Proliferative Diabetic Retinopathy. Investigative Ophthalmology & Visual Science, 40, 2453-2457.
|
[27]
|
Das, A., McGuire, P.G., Eriqat, C., et al. (1999) Human Dia-betic Neovascular Membranes Contain High Levels of Urokinase and Metalloproteinase Enzymes. Investigative Oph-thalmology & Visual Science, 40, 809-813.
|
[28]
|
Lee, C.H., Shieh, Y.S., Hsiao, F.C., et al. (2014) High Glucose In-duces Human Endothelial Dysfunction through an Axl-Dependent Mechanism. Cardiovascular Diabetology, 13, 53. https://doi.org/10.1186/1475-2840-13-53
|
[29]
|
Song, H., Wang, L. and Hui, Y. (2007) Expression of CD18 on the Neutrophils of Patients with Diabetic Retinopathy. Graefe’s Archive for Clinical and Experimental Ophthalmology, 245, 24-31. https://doi.org/10.1007/s00417-006-0379-2
|
[30]
|
Kociok, N., Radetzky, S., Krohne, T.U., et al. (2009) ICAM-1 Depletion Does Not Alter Retinal Vascular Development in a Model of Oxygen-Mediated Neovascularization. Exper-imental Eye Research, 89, 503-510. https://doi.org/10.1016/j.exer.2009.05.005
|
[31]
|
Bhatt, L.K. and Addepalli, V. (2010) Attenuation of Diabetic Retinopathy by Enhanced Inhibition of MMP-2 and MMP-9 Using Aspirin and Minocycline in Streptozotocin-Diabetic Rats. American Journal of Translational Research, 2, 181-189.
|
[32]
|
Samtani, S., Amaral, J., Campos, M.M., et al. (2009) Doxycycline-Mediated Inhibition of Choroidal Neovascularization. Investigative Ophthalmology & Visual Science, 50, 5098-5106. https://doi.org/10.1167/iovs.08-3174
|
[33]
|
(2015) VEGF Inhibitors for AMD and Diabetic Macular Edema. JAMA, 314, 2184-2185. https://doi.org/10.1001/jama.2015.15427
|
[34]
|
Klaassen, I., Van Noorden, C.J. and Schlingemann, R.O. (2013) Molecular Basis of the Inner Blood-Retinal Barrier and Its Breakdown in Diabetic Macular Edema and Other Pathological Conditions. Progress in Retinal and Eye Research, 34, 19-48. https://doi.org/10.1016/j.preteyeres.2013.02.001
|
[35]
|
Yu, Y., Yang, L., Lv, J., et al. (2015) The Role of High Mobility Group Box 1 (HMGB-1) in the Diabetic Retinopathy Inflammation and Apoptosis. International Journal of Clinical and Experimental Pathology, 8, 6807-6813.
|
[36]
|
Santos, A.R., Dvoriantchikova, G., Li, Y., et al. (2014) Cellular Mechanisms of High Mobility Group 1 (HMGB-1) Protein Action in the Diabetic Retinopathy. PLoS ONE, 9, e87574. https://doi.org/10.1371/journal.pone.0087574
|
[37]
|
Clauss, M., Sunderkotter, C., Sveinbjornsson, B., et al. (2001) A Permissive Role for Tumor Necrosis Factor in Vascular Endothelial Growth Factor-Induced Vascular Permeability. Blood, 97, 1321-1329. https://doi.org/10.1182/blood.V97.5.1321
|
[38]
|
Joussen, A.M., Poulaki, V., Mitsiades, N., et al. (2002) Non-steroidal Anti-Inflammatory Drugs Prevent Early Diabetic Retinopathy via TNF-Alpha Suppression. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 16, 438-440. https://doi.org/10.1096/fj.01-0707fje
|
[39]
|
Jampol, L.M., Bressler, N.M. and Glassman, A.R. (2014) Revolution to a New Standard Treatment of Diabetic Macular Edema. JAMA, 311, 2269-2270. https://doi.org/10.1001/jama.2014.2536
|
[40]
|
Lu, X. and Sun, X. (2015) Profile of Conbercept in the Treatment of Neovascular Age-Related Macular Degeneration. Drug Design, Development and Therapy, 9, 2311-2320.
|
[41]
|
Wong, T.Y., Liew, G. and Mitchell, P. (2007) Clinical Update: New Treatments for Age-Related Macular Degeneration. The Lancet (London, England), 370, 204-206. https://doi.org/10.1016/S0140-6736(07)61104-0
|
[42]
|
Nguyen, Q.D., Brown, D.M., Marcus, D.M., et al. (2012) Ranibizumab for Diabetic Macular Edema: Results from 2 Phase III Randomized Trials: RISE and RIDE. Ophthalmology, 119, 789-801. https://doi.org/10.1016/j.ophtha.2011.12.039
|
[43]
|
Rajendram, R., Fraser-Bell, S., Kaines, A., et al. (2012) A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Man-agement of Diabetic Macular Edema: 24-Month Data: Report 3. Archives of Ophthalmology, 130, 972-979. https://doi.org/10.1001/archophthalmol.2012.393
|
[44]
|
Brown, D.M., Schmidt-Erfurth, U., Do, D.V., et al. (2015) Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results from the VISTA and VIVID Studies. Oph-thalmology, 122, 2044-2052. https://doi.org/10.1016/j.ophtha.2015.06.017
|
[45]
|
Michael, S. and Ip, M.D. (2008) A Randomized Trial Com-paring Intravitreal Triamcinolone Acetonide and Focal/Grid Photocoagulation for Diabetic Macular Edema. Ophthal-mology, 115, 1447-1449.
|
[46]
|
Ebneter, A. and Zinkernagel, M.S. (2016) Novelties in Diabetic Retinopathy. Endocrine Development, 31, 84-96. https://doi.org/10.1159/000439391
|
[47]
|
Zang, M., Zhu, F., Zhao, L., et al. (2014) The Effect of UGTs Polymor-phism on the Auto-Induction Phase II Metabolism-Mediated Pharmacokinetics of Dihydroartemisinin in Healthy Chinese Subjects after Oral Administration of a Fixed Combination of Dihydroartemisinin-Piperaquine. Malaria Journal, 13, 478. https://doi.org/10.1186/1475-2875-13-478
|
[48]
|
Efferth, T., Sauerbrey, A., Olbrich, A., et al. (2003) Molecular Modes of Action of Artesunate in Tumor Cell Lines. Molecular Pharmacology, 64, 382-394. https://doi.org/10.1124/mol.64.2.382
|
[49]
|
Berger, T.G., Dieckmann, D., Efferth, T., et al. (2005) Artesunate in the Treatment of Metastatic Uveal Melanoma—First Experiences. Oncology Reports, 14, 1599-1603. https://doi.org/10.3892/or.14.6.1599
|
[50]
|
White, N.J., Ashley, E.A. and Nosten, F. (2006) Toxic Brainstem En-cephalopathy after Artemisinin Treatment for Breast Cancer. Annals of Neurology, 59, 725-726. https://doi.org/10.1002/ana.20815
|
[51]
|
Crespo-Ortiz, M.P. and Wei, M.Q. (2012) Antitumor Activity of Arte-misinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug. Journal of Biomed-icine & Biotechnology, 2012, Article ID: 247597. https://doi.org/10.1155/2012/247597
|
[52]
|
Ba, Q., Duan, J., Tian, J.Q., et al. (2013) Dihydroartemisinin Promotes Angiogenesis during the Early Embryonic Development of Zebrafish. Acta Pharmacologica Sinica, 34, 1101-1107. https://doi.org/10.1038/aps.2013.48
|
[53]
|
D’Alessandro, S., Gelati, M., Basilico, N., et al. (2007) Differential Ef-fects on Angiogenesis of Two Antimalarial Compounds, Dihydroartemisinin and Artemisone: Implications for Embry-otoxicity. Toxicology, 241, 66-74. https://doi.org/10.1016/j.tox.2007.08.084
|